Trials / Completed
CompletedNCT01447095
Effects of Prostacyclin Infusion on Cerebral Vessels and Metabolism in Patients With Subarachnoid Haemorrhage
Effect of Prostacyclin Infusion on Cerebral Vessels, Cerebral Bloodflow and Cerebral Metabolism in Patients With Subarachnoid Haemorrhage
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Rune Rasmussen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether prostacyclin is effective in prevention of cerebral vasospasm in patients with subarachnoidal hemorrhage (SAH).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Prostacyclin 1 ng/kg/min | Continuous i.v. infusion of epoprostenol 1 ng/kg/min day 5-10 after SAH |
| DRUG | Prostacyclin 2 ng/kg/min | Continuous i.v. infusion of epoprostenol 2 ng/kg/min day 5-10 after SAH |
| DRUG | Placebo | Continuous i.v. infusion with placebo day 5-10 after SAH |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2014-06-01
- Completion
- 2014-06-01
- First posted
- 2011-10-05
- Last updated
- 2014-07-21
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01447095. Inclusion in this directory is not an endorsement.